Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Type 16”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT01627561
What this trial is testing

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 148
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Not applicableUnknownNCT05905354
What this trial is testing

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

Who this might be right for
HSIL of Cervix
Newish Technology (Beijing) Co., Ltd. 12
Testing effectiveness (Phase 2)UnknownNCT06015854
What this trial is testing

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II

Who this might be right for
CIN3Cervical Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 3+1 more
University Medical Center Groningen 18
Testing effectiveness (Phase 2)Study completedNCT00693615
What this trial is testing

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 60
Not applicableUnknownNCT05587738
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 4

Who this might be right for
Human Papillomavirus InfectionHPVHPV Infection+4 more
Monash University 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06866574
What this trial is testing

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Who this might be right for
Penile/Perineal /Perianal Intraepithelial NeoplasiaAnal Intraepithelial NeoplasiaPenile/Perianal/Perineal Cancer+2 more
Xiamen University 9,300
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Testing effectiveness (Phase 2)Study completedNCT00365716
What this trial is testing

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Who this might be right for
Papillomavirus InfectionsGenital Diseases, Female
Merck Sharp & Dohme LLC 1,158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Early research (Phase 1)Study completedNCT03085381
What this trial is testing

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Bovax Biotechnology Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT03444376
What this trial is testing

The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Genexine, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT02865135
What this trial is testing

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Who this might be right for
Cancer of Head and NeckCancer of CervixCancer of Anus
Dana-Farber Cancer Institute 11
Large-scale testing (Phase 3)Study completedNCT03721978
What this trial is testing

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Who this might be right for
Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL
Inovio Pharmaceuticals 203
Not applicableStudy completedNCT04000503
What this trial is testing

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

Who this might be right for
Human Papillomavirus 16Human Papillomavirus 18Papillomavirus Infections+2 more
University of British Columbia 2,019
Not applicableStudy completedNCT01520272
What this trial is testing

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

Who this might be right for
HPV16 Anitbody Levels Post VaccinationHPV18 Antibody Levels Post Vaccination
National Cancer Institute (NCI) 376
Post-approval studies (Phase 4)Active Not RecruitingNCT07314307
What this trial is testing

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Who this might be right for
Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Karolinska Institutet 150,000
Next Page